Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)

By sjmartinez • May 14, 2024

Razavi AC, Richardson LC, Coronado F, Dzaye O, Bhatia HS, Mehta A, Quyyumi AA, Vaccarino V, Budoff MJ, Nasir K, Tsimikas S, Whelton SP, Blaha MJ, Blumenthal RS, Sperling LS. Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a). Am J Prev Cardiol. 2024 Apr 27;18:100674. doi: 10.1016/j.ajpc.2024.100674. PMID: 38741703; PMCID: PMC11090055.

Tags: Aspirin, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipoprotein(a), NHANES, Publications

Heart Failure and Gut Microbiota: What Is Cause and Effect?

Shen S, Tian B, Zhang H, Wang YC, Li T, Cao Y. Heart Failure and Gut Microbiota: What Is Cause and Effect? Research (Wash D[...]

Amara Yad Image: Myocardial Scar

Mori S, Fishbein MC, Shivkumar K. Amara Yad Image: Myocardial Scar. J Am Coll Cardiol. 2025 Feb 25;85(7):782-783. doi: 10.1016/j.jacc.2025.01.004. PMID: 39971411.

Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging

Rozanski A, Gransar H, Miller RJH, Han D, Hayes SW, Friedman JD, Thomson L, Lavie CJ, Berman DS. Comparative Predictors of Mortality Risk in Contemporary[...]